Clinical Trials
3
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics
Recruiting
- Conditions
- Non Small Cell Lung CancerHealthy
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- OncoHost Ltd.
- Target Recruit Count
- 350
- Registration Number
- NCT05736029
- Locations
- 🇺🇸
Baylor Scott and White Research Institute, Dallas, Texas, United States
Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients
Suspended
- Conditions
- Glioblastoma
- First Posted Date
- 2020-01-07
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- OncoHost Ltd.
- Target Recruit Count
- 1000
- Registration Number
- NCT04219475
- Locations
- 🇮🇱
Rambam medical center, Haifa, Israel
🇮🇱Rabin medical center, Petah tikva, Israel
🇮🇱Sourasky medical center, Tel Aviv, Israel
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
Recruiting
- Conditions
- Stage IV Non-small Cell Lung CancerStage IV Malignant MelanomaStage IV Small Cell Lung CancerStage III Malignant Melanoma
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- OncoHost Ltd.
- Target Recruit Count
- 2000
- Registration Number
- NCT04056247
- Locations
- 🇺🇸
Birmingham VAHCS, Birmingham, Alabama, United States
🇺🇸Mayo Clinic, Jacksonville, Florida, United States
🇺🇸University of Miami, Miami, Florida, United States
News
No news found